Advisory Board
Sentinel's buy-side work is backed by senior operators and investors who've built, bought, and sold in the sectors we source — standing counsel for our partners' hardest calls, not a name on a slide.
Who They Are
Every seat on this board earned its place the hard way — inside the deals, not on the sidelines of them. Three domains of coverage, chosen because they map directly onto where our partners' hardest questions actually come from.
Founders and executives who scaled and exited multi-location healthcare platforms — the exact path our partners are on, told from the seat that lived it.
Investors who've deployed capital across dozens of add-on and platform deals — advising on structure, thesis, and where a mandate is worth pushing harder.
Operators who've integrated acquisitions and know what makes a target worth pursuing beyond the numbers — and what quietly kills a deal after close.
Advisory board members are introduced by name to partners under engagement. Confidentiality runs both ways — we never publish a roster, and neither do you.
Why It Matters To You
When a live target raises a hard question, the person who answers it has usually already lived the answer. That's the difference between a list vendor and a corporate development partner.
"Is this valuation getting ahead of the market?"
answered by →"Should this be a rollover or a clean exit?"
answered by →"Can we actually integrate this in six months?"
answered by →Advisory board members are introduced by name to partners under engagement — never published, never a logo on a page.
Confidential by policy · runs both ways
Tell us your mandate — a principal replies within one business day, and the right seat is in the room from your first serious question onward.